T-cell immunotherapy market is projected to grow at an annualized rate of 12.2% by 2030
Driven by high success rates in clinical trials and the potential to confer sustained periods of disease remission, T-cell therapies have received significant financial support, with approved products poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition)-Distribution by Type of Therapy...
0 Comentários
0 Compartilhamentos